
The Next Frontier of Microbiome Science
Prebiotics, probiotics, and postbiotics aren't just for gut support anymore. How can the microbes in your gut affect the health of your whole body?
Prebiotics, probiotics, and postbiotics aren't just for gut support anymore. How can the microbes in your gut affect the health of your whole body?
Clinically validated resB® Lung Support contains a proprietary blend of well-studied probiotic strains and ancient herbs scientifically engineered to support lung structure and function, gut health, and immune health.* Our extensive preclinical and clinical data obtained through rigorous in vitro testing and human clinical trials make resB® one of the most rigorously studied probiotic supplements today.
prebeet® is your daily 4-in-1 microbiome boost containing prebiotic fiber, beet root, and vitamin B12 to supercharge your energy, encourage regular bowel movements, restore skin balance, and improve heart health with its clinically studied all-natural formulation.
From ingredient sourcing, preclinical testing, and product formulation to third-party stability testing, we collaborate with the world’s leading scientists, research partners, and manufacturers. We do all this to develop the first microbiome-based, clinically validated nutritional interventions for day-to-day health.
Founder & CEO
Chief Medical Officer
Director, Lab Operations
Advisor (Pediatric Lung Disease)
Endowed Professor & Virginia Walker Chair in Pediatrics, University of Alabama at Birmingham
Advisor (Microbiome, Adult Lung Disease)
Associate Professor, Pulmonary & Critical Care Medicine & Director Huang Microbiome Lab, University of Michigan
Advisor (Lung Transplant)
Assistant Professor Medical Director Lung Transplantation Program, Brigham & Women’s, Harvard University
Advisor (Gut-Lung Axis, Mycobiome)
Assistant Professor & Director, Willis Lung Lab, University of Alabama at Birmingham
Advisor (Clinical Trials, Adult Lung Disease)
Associate Professor, Pulmonary & Critical Care Medicine, University of Alabama at Birmingham
Advisor (Microbiome)
Professor Emeritus, Microbiome Resource Center & Cell Development & Integrative Biology, University of Alabama at Birmingham
Completed and ongoing studies of resB® Lung Support include
This was a randomized, open-label clinical trial in Cork, Ireland with healthy and asthmatic patients who took one resB® capsule twice daily (one in the morning, one at night) for one month.
Primary outcomes include testing safety measures. All participants tolerated the blend without adverse events.
Exploratory outcomes investigated changes in gut microbiota, serum MMP-9 and cytokines, CRP, lung function, oxygen levels, and changes in quality of life.
Completed 2022 – View Results
This is a multi-center randomized control trial in the United States with a dosing period of three months.
Primary outcomes center on change in quality of life.
Exploratory outcomes investigate clinical improvement markers (e.g., FEV1/FVC), gut and
lung microbiota, systemic and pulmonary biomarker changes (e.g., MMP-9, CRP,
cytokines, etc.)
This is a single-center randomized control trial in India with a dosing period of 14 days.
Primary outcomes center around pneumonia incidence and prognosis in elderly population in an acute care setting.
Your cart is currently empty.